Grids Moving into Strategic New Roles


By Salvatore Salamone Bio-IT World

The role of computing grids is on the cusp of a fundamental change.

Grids are shifting from being essentially IT infrastructure tools that tie together computing resources to playing a more central role in providing services to researchers. At the same time, the use of grids is also morphing from one that was exclusively the purview of academics and researchers to a state where organizations view grid technology as critical infrastructure needed to support their business operations.

The shift is duly noted by the Global Grid Forum (GGF), the organization that helps develop grid standards and specifications for grid interoperability. “We started about five years ago within the academic and research community,” says Mark Linesch, who has served as chairman of the GGF since September 2004. But he notes membership has expanded to include members from many commercial organizations representing a wide range of industries.

“We have been successful in phase one – the introduction of grids,” says Linesch. “We focused on compute issues and bringing data together in a federated [type of] approach.”

This focus reflects the use of grids over the time period leading up to today. Notably, for about the last five years, grids have increasingly been used in life sciences and other industries to harness CPU resources to apply more processing power to computational problems.

Deployments over the last few years have proved the value of grid technology, and as such, grids have gained respectability as true corporate platforms for computing. And this leads to the new phase in grids usage that Linesch refers to. “We need to look at grids in a broader distributed computing sense,” says Linesch. “Over the next five years, grids will allow sharing of resources and will connect users to disparate resources enabling [the delivery of] IT as a service.”

To bring grids into this next stage of use, the GGF has research and working groups that are developing grid specifications and best practices for grids in general and for industry-specific applications.

Some efforts cut across all industries. For instance, security and architectural issues like how to support and use Web services technologies are important to anyone interested in grids today. Other issues – such as authentication, provisioning, and data management – that have to do with interoperability, also cut across most applications.

In such areas, the GGF develops its own specifications, but also reaches out to other organizations to leverage the work already done by other groups. These include the W3C (World Wide Web Consortium) and OASIS (the Organization for the Advancement of Structured Information Standards). The GGF also has liaisons with the IETF (Internet Engineering Task Force), DMTF (Distributed Management Task Force), and the SNIA (Storage Networking Industry Association).

While many issues apply to all users, different industries have different requirements, so some of the GGF groups tackle industry-specific application issues. For instance, there is a life science grid group that looks at the issues related to the integration of IT with life science applications on a grid infrastructure.

Within such groups, the focus is on developing use cases and best practices for a particular industry. For instance, a healthcare effort naturally could use all of the general grid architectural specifications, but it also focuses on how to meet HIPAA (Health Insurance Portability and Accounting Act) regulations in a grid environment.

To move grids into that next level of enablers of IT services, the GGF will use next week’s GridWorld conference in Boston, Mass., to announce a formal roadmap. The roadmap will set grid computing and grid computing standards into a broader distributed computing context.

(More information will be published in the October issue of Bio-IT World.)

Related stories:

Grid Computing: Turning Hype into Reality

Vendors Bullish on Grid Computing

IBM Offers Starter Pack for Grid Computing

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.